Augmedics Raises $36 Million in Series C Round

Augmedics xvision

Augmedics raised $36 million in an oversubscribed Series C financing. This comes eight months after the company closed a $21 million Series B, bringing the total funding to date to $63 million.

Funds will support continued U.S. commercialization and development in ex-U.S. markets for the xvision Spine system, as well as next-gen products,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us